000 01653 a2200469 4500
005 20250516104941.0
264 0 _c20121203
008 201212s 0 0 eng d
022 _a1432-0843
024 7 _a10.1007/s00280-012-1943-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Yeul Hong
245 0 0 _aA phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cOct 2012
300 _a583-90 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aEpothilones
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aStomach Neoplasms
_xdrug therapy
650 0 4 _aTubulin Modulators
_xtherapeutic use
700 1 _aMuro, Kei
700 1 _aYasui, Hirofumi
700 1 _aChen, Jen-Shi
700 1 _aRyu, Min-Hee
700 1 _aPark, Se-Hoon
700 1 _aChu, Kent-Man
700 1 _aChoo, Su-Pin
700 1 _aSanchez, Teresa
700 1 _aDelaCruz, Christine
700 1 _aMukhopadhyay, Pralay
700 1 _aLainas, Ioannis
700 1 _aLi, Chung-Pin
773 0 _tCancer chemotherapy and pharmacology
_gvol. 70
_gno. 4
_gp. 583-90
856 4 0 _uhttps://doi.org/10.1007/s00280-012-1943-6
_zAvailable from publisher's website
999 _c22018898
_d22018898